Connection

M Halloran to Humans

Back to Details
This is a "connection" page, showing publications M Halloran has written about Humans.
M Halloran
Connection Strength
0.075
Humans
  1. Comment on AIDS and COVID-19: A tale of two pandemics and the role of statisticians. Stat Med. 2021 05 20; 40(11):2524-2525.
    View in: PubMed
    Score: 0.008
  2. Evaluation and comparison of predictive individual-level general surrogates. Biostatistics. 2018 07 01; 19(3):307-324.
    View in: PubMed
    Score: 0.006
  3. Estimating population effects of vaccination using large, routinely collected data. Stat Med. 2018 Jan 30; 37(2):294-301.
    View in: PubMed
    Score: 0.006
  4. Ebola: mobility data. Science. 2014 Oct 24; 346(6208):433.
    View in: PubMed
    Score: 0.005
  5. Components of the indirect effect in vaccine trials: identification of contagion and infectiousness effects. Epidemiology. 2012 Sep; 23(5):751-61.
    View in: PubMed
    Score: 0.004
  6. Factors Associated With Household Transmission of SARS-CoV-2: An Updated Systematic Review and Meta-analysis. JAMA Netw Open. 2021 08 02; 4(8):e2122240.
    View in: PubMed
    Score: 0.002
  7. Household transmission of SARS-CoV-2 and risk factors for susceptibility and infectivity in Wuhan: a retrospective observational study. Lancet Infect Dis. 2021 05; 21(5):617-628.
    View in: PubMed
    Score: 0.002
  8. Household Transmission of SARS-CoV-2: A Systematic Review and Meta-analysis. JAMA Netw Open. 2020 12 01; 3(12):e2031756.
    View in: PubMed
    Score: 0.002
  9. Ensemble forecast modeling for the design of COVID-19 vaccine efficacy trials. Vaccine. 2020 10 27; 38(46):7213-7216.
    View in: PubMed
    Score: 0.002
  10. Modelling the impact of testing, contact tracing and household quarantine on second waves of COVID-19. Nat Hum Behav. 2020 09; 4(9):964-971.
    View in: PubMed
    Score: 0.002
  11. Aggregating data from COVID-19 trials. Science. 2020 06 12; 368(6496):1198-1199.
    View in: PubMed
    Score: 0.002
  12. Multigroup, Adaptively Randomized Trials Are Advantageous for Comparing Coronavirus Disease 2019 (COVID-19) Interventions. Ann Intern Med. 2020 10 06; 173(7):576-577.
    View in: PubMed
    Score: 0.002
  13. Reply to Lindsey, Höschler, and de Silva. Clin Infect Dis. 2020 05 06; 70(10):2236-2237.
    View in: PubMed
    Score: 0.002
  14. Evolving epidemiology and transmission dynamics of coronavirus disease 2019 outside Hubei province, China: a descriptive and modelling study. Lancet Infect Dis. 2020 07; 20(7):793-802.
    View in: PubMed
    Score: 0.002
  15. Aggregated mobility data could help fight COVID-19. Science. 2020 04 10; 368(6487):145-146.
    View in: PubMed
    Score: 0.002
  16. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science. 2020 04 24; 368(6489):395-400.
    View in: PubMed
    Score: 0.002
  17. Reply to Skowronski and De Serres. Clin Infect Dis. 2019 11 27; 69(12):2231-2232.
    View in: PubMed
    Score: 0.002
  18. Epidemiology of dengue and other arboviruses in a cohort of school children and their families in Yucatan, Mexico: Baseline and first year follow-up. PLoS Negl Trop Dis. 2018 11; 12(11):e0006847.
    View in: PubMed
    Score: 0.002
  19. Dengue seroprevalence in a cohort of schoolchildren and their siblings in Yucatan, Mexico (2015-2016). PLoS Negl Trop Dis. 2018 11; 12(11):e0006748.
    View in: PubMed
    Score: 0.002
  20. Quantifying the risk of local Zika virus transmission in the contiguous US during the 2015-2016 ZIKV epidemic. BMC Med. 2018 10 18; 16(1):195.
    View in: PubMed
    Score: 0.002
  21. Transmissibility of Norovirus in Urban Versus Rural Households in a Large Community Outbreak in China. Epidemiology. 2018 09; 29(5):675-683.
    View in: PubMed
    Score: 0.002
  22. Intermediate levels of vaccination coverage may minimize seasonal influenza outbreaks. PLoS One. 2018; 13(6):e0199674.
    View in: PubMed
    Score: 0.002
  23. Forecasting the effectiveness of indoor residual spraying for reducing dengue burden. PLoS Negl Trop Dis. 2018 06; 12(6):e0006570.
    View in: PubMed
    Score: 0.002
  24. Spatio-temporal coherence of dengue, chikungunya and Zika outbreaks in Merida, Mexico. PLoS Negl Trop Dis. 2018 03; 12(3):e0006298.
    View in: PubMed
    Score: 0.002
  25. Efficacy of a bivalent killed whole-cell cholera vaccine over five years: a re-analysis of a cluster-randomized trial. BMC Infect Dis. 2018 02 20; 18(1):84.
    View in: PubMed
    Score: 0.002
  26. Seroprevalence of Dengue Antibodies in Three Urban Settings in Yucatan, Mexico. Am J Trop Med Hyg. 2018 04; 98(4):1202-1208.
    View in: PubMed
    Score: 0.002
  27. An Assessment of Household and Individual-Level Mosquito Prevention Methods during the Chikungunya Virus Outbreak in the United States Virgin Islands, 2014-2015. Am J Trop Med Hyg. 2018 03; 98(3):845-848.
    View in: PubMed
    Score: 0.002
  28. Dependency of Vaccine Efficacy on Preexposure and Age: A Closer Look at a Tetravalent Dengue Vaccine. Clin Infect Dis. 2018 01 06; 66(2):178-184.
    View in: PubMed
    Score: 0.001
  29. Meningococcal carriage within households in the African meningitis belt: A longitudinal pilot study. J Infect. 2018 02; 76(2):140-148.
    View in: PubMed
    Score: 0.001
  30. Antibody-dependent enhancement of severe dengue disease in humans. Science. 2017 11 17; 358(6365):929-932.
    View in: PubMed
    Score: 0.001
  31. Zika virus evolution and spread in the Americas. Nature. 2017 06 15; 546(7658):411-415.
    View in: PubMed
    Score: 0.001
  32. Spread of Zika virus in the Americas. Proc Natl Acad Sci U S A. 2017 05 30; 114(22):E4334-E4343.
    View in: PubMed
    Score: 0.001
  33. Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: A cluster-randomized trial. PLoS Med. 2017 Apr; 14(4):e1002282.
    View in: PubMed
    Score: 0.001
  34. FluTE, a publicly available stochastic influenza epidemic simulation model. PLoS Comput Biol. 2010 Jan 29; 6(1):e1000656.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.